APNHY (APNHY) Stock Price & Analysis
APNHY (APNHY) rose 1.80% to USD 9.03 as of June 10, 2026 at 02:15 UTC, according to Nexqual real-time market data.
APNHY last closed at USD 8.87; the session ranged USD 9.03–9.03 on volume of 3 shares. Market capitalization is $4.01B, with a 52-week range of USD 5.24–9.03 (PNK). Source: Nexqual, June 10, 2026 at 02:15 UTC.
Key Statistics (as of June 10, 2026 at 02:15 UTC)
| Price | USD 9.03 |
|---|---|
| Change | ▲ 1.80% (up) |
| Previous Close | USD 8.87 |
| Open | USD 9.03 |
| Day Range | USD 9.03 – 9.03 |
| 52-Week Range | USD 5.24 – 9.03 |
| Volume | 3 shares |
| Market Cap | $4.01B |
| Exchange | PNK |
Technical Analysis (APNHY)
Nexqual's technical model rates APNHY "BUY" based on 5 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 02:15 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 66.54 (neutral) |
| vs SMA50 | Above (USD 8.31) |
| MACD | 0.15 (positive) |
Analyst Ratings (APNHY)
Wall Street analysts rate APNHY "None", per Nexqual as of June 10, 2026 at 02:15 UTC.
| Consensus Rating | None |
|---|
Earnings (APNHY)
Source: Nexqual, June 10, 2026 at 02:15 UTC.
Financials & Fundamentals (APNHY)
| Total Revenue | $42.59B |
|---|---|
| Revenue Growth (YoY) | -4.30% |
| Gross Margin | +42.99% |
| Operating Margin | +10.66% |
| Profit Margin | -4.69% |
| ROE | -2.17% |
| Debt / Equity | 40.63 |
| Current Ratio | 3.64 |
| Total Cash | $5.62B |
| Total Debt | $32.94B |
| Free Cash Flow | $-17.68B |
Source: Nexqual, June 10, 2026 at 02:15 UTC.
Financial Health Score (APNHY)
Nexqual rates APNHY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:15 UTC.
| Growth | Weak — Revenue -3% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 43%, operating 11% |
| Balance Sheet | Strong — $5.62B cash vs $32.9B debt |
| Cash Flow | Weak — FCF negative: -$17.7B, burning cash |
| Efficiency | Critical — ROE -2%, ROA 2.9% |
Ownership (APNHY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 444.02M |
| Float | 366.58M |
Source: Nexqual, June 10, 2026 at 02:15 UTC.
Leadership (APNHY)
APNHY is led by Stephen Bradley Saad BCom, CA(SA) (age 61), Group CEO & Executive Director, per Nexqual as of June 10, 2026 at 02:15 UTC.
| Group CEO & Executive Director | Stephen Bradley Saad BCom, CA(SA) (age 61) |
|---|---|
| Group CFO & Executive Director | Sean M. Capazorio (age 58) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BDVSY | Bidvest Group Ltd. | USD 28.27 | ▲ 0.96% |
| CLCGY | Clicks Group Ltd | USD 28.49 | ▲ 0.35% |
| IPSEY | Ipsen S.A. | USD 42.27 | ▼ 6.15% |
| HYPMY | Hypera SA | USD 3.96 | ▼ 5.71% |
| SNPHY | Santen Pharmaceutical Co., Ltd. | USD 12.2 | ▲ 3.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:15 UTC. This page is informational and not investment advice.